Paternal preconception donepezil exposure enhances learning in offspring.
Behav Brain Funct
; 20(1): 25, 2024 Sep 28.
Article
in En
| MEDLINE
| ID: mdl-39342229
ABSTRACT
BACKGROUND:
Recent research has indicated that parental use of central nervous system-targeting medications during periconceptional periods may affect offspring across various developmental and behavioral domains. The present study sought to investigate the potential influence of paternal use of donepezil, a specific reversible central acetylcholinesterase inhibitor that activates the cholinergic system to promote cognition, on offspring.RESULTS:
In this study, male rats were bred after 21 days of oral donepezil administration at a dose of 4 mg/kg to generate F1 offspring. Both male and female F1 offspring displayed enhanced performance in learning and short-term memory tests, including novel object recognition, Y maze, and operant learning. Transcriptomic analysis revealed notable alterations in genes associated with the extracellular matrix in the hippocampal tissue of the F1 generation. Integration with genes related to intelligence identified potential core genes that may be involved in the observed behavioral enhancements.CONCLUSIONS:
These findings indicate that prolonged paternal exposure to donepezil may enhance the learning and memory abilities of offspring, possibly by targeting nonneural, extracellular regions. Further research is required to fully elucidate any potential transgenerational effects.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cholinesterase Inhibitors
/
Paternal Exposure
/
Donepezil
Limits:
Animals
/
Pregnancy
Language:
En
Journal:
Behav Brain Funct
Journal subject:
CEREBRO
/
CIENCIAS DO COMPORTAMENTO
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido